Thermo Fisher Scientific Inc. TMO
NYSE
| 09/26/2026 | 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.13% | 10.50% | 6.18% | 7.20% | 4.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.13% | 10.49% | 6.18% | 7.20% | 4.94% |
| Cost of Revenue | 7.17% | 10.07% | 7.24% | 9.46% | 4.28% |
| Gross Profit | 11.91% | 11.11% | 4.66% | 4.13% | 5.90% |
| SG&A Expenses | 11.58% | 8.35% | 3.59% | 2.71% | 0.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -550.00% | -- |
| Total Operating Expenses | 7.95% | 9.40% | 6.01% | 5.43% | 3.30% |
| Operating Income | 14.05% | 15.51% | 7.01% | 14.32% | 12.40% |
| Income Before Tax | 13.73% | 11.51% | 7.47% | 7.55% | 5.73% |
| Income Tax Expenses | 70.05% | 81.52% | -26.32% | 2.00% | 109.09% |
| Earnings from Continuing Operations | 6.54% | 7.54% | 9.60% | 8.00% | -0.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -20.00% | -150.00% | -25.00% | -200.00% | -- |
| Net Income | 6.50% | 7.36% | 9.56% | 7.32% | -0.86% |
| EBIT | 14.05% | 15.51% | 7.01% | 14.32% | 12.40% |
| EBITDA | 16.58% | 16.52% | 6.21% | 10.32% | 5.56% |
| EPS Basic | 8.80% | 9.38% | 11.32% | 9.03% | 0.19% |
| Normalized Basic EPS | 14.45% | 13.92% | 7.65% | 11.86% | 13.08% |
| EPS Diluted | 8.67% | 9.38% | 11.31% | 8.59% | 0.47% |
| Normalized Diluted EPS | 14.15% | 13.92% | 7.65% | 11.86% | 13.67% |
| Average Basic Shares Outstanding | -2.12% | -1.85% | -1.59% | -1.57% | -1.05% |
| Average Diluted Shares Outstanding | -1.85% | -1.85% | -1.58% | -1.57% | -1.56% |
| Dividend Per Share | 9.30% | 9.30% | 9.30% | 10.26% | 10.26% |
| Payout Ratio | 0.00% | 0.01% | -0.01% | 0.01% | 0.10% |